SPARC boost cholesterol-dependent aggressive phenotype and sorafenib resistance in hepatocellular carcinoma
Ontology highlight
ABSTRACT: SPARC boost cholesterol-dependent aggressive phenotype and sorafenib resistance in hepatocellular carcinoma
PROVIDER: PRJNA1005188 | ENA |
REPOSITORIES: ENA
ACCESS DATA